What Happened?
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell 8.5% in the morning session after the company reported disappointing first-quarter 2026 results, where a significant earnings miss and worsening profitability overshadowed a revenue beat.
The company posted a GAAP loss per share of $0.12, a significant miss compared to analysts' consensus estimates of a $0.01 loss and a deterioration from the $0.05 loss in the same quarter last year. While revenue grew 5.4% year-on-year to $819.8 million, beating expectations, investors were clearly focused on the company’s strained profitability. This was evidenced by the operating margin contracting sharply to 0.7% from 3% a year earlier.
Furthermore, Adjusted EBITDA of $121.2 million missed analyst targets, and the company burned through $27.5 million in cash, a substantial increase from the prior year. Despite slightly raising its full-year revenue guidance, the poor bottom-line performance fueled investor concerns about rising costs and operational efficiency.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
What Is The Market Telling Us
AdaptHealth’s shares are quite volatile and have had 16 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 2 months ago when the stock dropped 16.4% on the news that its fourth-quarter 2025 report revealed a significant loss that overshadowed a revenue beat. While total revenue of $846.3 million surpassed analyst expectations, investors focused on substantial profitability challenges. The company posted a GAAP loss of $0.76 per share, which starkly missed Wall Street's consensus estimate for a $0.35 profit and reversed the $0.37 profit per share reported in the same quarter of the previous year. Highlighting the pressure on profits, the operating margin contracted to negative 8.7% from a positive 11.4% a year ago. Additionally, adjusted EBITDA, a measure of operational profitability, came in at $163.1 million, missing analyst forecasts by over 14%.
AdaptHealth is up 21.3% since the beginning of the year, but at $11.73 per share, it is still trading 12.4% below its 52-week high of $13.38 from April 2026. Despite the year-to-date gain, investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at only $407.12.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.